Effect of a JAK inhibitor on gene expression of HUT78 cell line
收藏官方服务：
资源简介：
Effect of a JAK inhibitor on gene expression of HUT78 cell line
应用场景：
创建时间：
2015-10-31
相关数据集
Patient Demographics and Response to JAK Inhibitor Therapy
This table presents a summary of various studies investigating the use of Janus kinase (JAK) inhibitors in treating different forms of scarring alopecia.
NIAID Data Ecosystem40
Acquired mutations within the JAK2 kinase domain confer resistance to type-I and type-II JAK inhibitors in in vitro models of a high-risk acute lymphoblastic leukemia
Ruxolitinib (rux) Phase II clinical trials are underway for the treatment of high-risk JAK2-rearranged (JAK2r) B-cell acute lymphoblastic leukemia (B-ALL). Treatment resistance to targeted inhibitors
NIAID Data Ecosystem30
DataSheet_1_Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis.pdf
IntroductionWe performed a single-arm meta-analysis to evaluate the efficacy and safety of JAK inhibitors in the treatment of dermatomyositis (DM)/ polymyositis (PM). MethodsRelevant studies from four
NIAID Data Ecosystem20
Oral JAK Inhibitors in the Management of Nail Psoriasis: An Evidence Based Review
Nail psoriasis is a manifestation of psoriasis localized to the nails, often presenting with pitting, onycholysis, and subungual hyperkeratosis. Currently, there are no FDA approved treatments specifi
Mendeley Data40
Management of Vitiligo with Topical JAK Inhibitor Therapy: An Evidence-Based Review
Vitiligo is an acquired progressive skin disorder characterized by hypopigmentation due to absence of functional melanocytes affecting up to 1% of the general population. Initial treatment typically i
NIAID Data Ecosystem20
